Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where N.A. Mark Estes is active.

Publication


Featured researches published by N.A. Mark Estes.


Circulation | 2012

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Cynthia M. Tracy; Andrew E. Epstein; Dawood Darbar; John P. DiMarco; Sandra B. Dunbar; N.A. Mark Estes; T. Bruce Ferguson; Stephen C. Hammill; Pamela Karasik; Mark S. Link; Joseph E. Marine; Mark H. Schoenfeld; Amit J. Shanker; Michael J. Silka; Lynne W. Stevenson; William G. Stevenson; Paul D. Varosy

Developed in Collaboration With the American Association for Thoracic Surgery, Heart Failure Society of America, and Society of Thoracic Surgeons


Archive | 2002

Long QT Syndrome, Brugada Syndrome, Right Ventricular Cardiomyopathy, Hypertrophic Cardiomyopathy, and Commotio Cordis

Eric Rashba; Mark S. Link; N.A. Mark Estes

The hereditary long QT syndrome (LQTS) is a rare disorder characterized by prolongation of the QT interval on the electrocardiogram (ECG) and a propensity for syncope, torsades de pointes, ventricular arrhythmias, and sudden death. One form of LQTS, described by Jervell and Lange-Neilsen in 1957, is characterized by deafness and autosomal recessive inheritance (1). The most common form of LQTS was initially described by Romano (2) and Ward (3), and is characterized by autosomal dominant inheritance and normal hearing. Remarkable progress has been made in the last several years in our understanding of the pathogenesis of LQTS. It is now clear that LQTS is a heterogeneous disorder caused by mutations in specific ion channels that play a critical role in the control of cardiac repolarization (4). These findings have revolutionized our understanding of LQTS, and may yield new insights into other conditions characterized by ventricular arrhythmias in the absence of ischemia or structural heart disease. Recent work has also identified LQTS as an important cause of sudden infant death syndrome (SIDS) (5,6).


Archive | 2001

The Advantages and Disadvantages of Creating Large Radiofrequency Ablation Lesions

Munther K. Homoud; Craig Swygman; Mark S. Link; Caroline Foote; N.A. Mark Estes; Paul J. Wang

Radiofrequency ablation has become a major therapeutic modality in the treatment of cardiac arrhythmias. Most forms of supraventricular tachycardia have been successfully treated with catheter-based techniques using focal ablative radiofrequency lesions. A large range of other arrhythmias, however, may be treated using longer, wider, and deeper lesions. A long linear lesion may be particularly important in the ablation of reentrant arrhythmias that have a critical zone 1-cm or more in length. Such a critical zone may exist between two or more anatomic structures, such as in atrial flutter, scar-related reentrant tachycardias, some atrial tachycardias, and some ventricular tachycardias (Figure 1). A series of linear lesions may also be effective in preventing perpetuation of reentrant wavefronts in such disorders as atrial fibrillation (Figure 2). A line of lesions may be placed circumferentially when it is not possible or desirable to ablate the arrhythmia focus itself (Figure 3). This approach may be useful in some ventricular tachycardias and in focal atrial fibrillation ablation in pulmonary veins. There are situations in which the reentrant circuit may be complex and it is not possible to ablate all the critical zones. It may be possible to transect the zone in such cases as ischemic-based ventricular tachycardia (Figure 4). Wide lesions may be necessary when the reentrant circuit spans a large surface area subendocardial (Figure 5).


Syncope: Mechanisms and Management, Second Edition | 2007

Chapter 17. Syncope in the Athlete

Olaf Hedrich; Mark S. Link; Munther K. Homoud Md and; N.A. Mark Estes


Cardiac Electrophysiology: From Cell to Bedside (Seventh Edition) | 2018

108 – Sudden Cardiac Deaths in Athletes, Including Commotio Cordis

Mark S. Link; N.A. Mark Estes


Archive | 2012

Principles of Catheter Ablation

Ann C. Garlitski; Munther K. Homoud; N.A. Mark Estes


/data/revues/08947317/v8i3/S0894731705800513/ | 2011

Potential of three-dimensional echocardiography in the interventional electrophysiology laboratory: Experimental studies and initial clinical experience

Alain Delabays; Natesa Pandian; Qi-Ling Cao; Lissa Sugeng; N.A. Mark Estes; Paul J. Wang


New Arrhythmia Technologies | 2007

New Developments in Noninvasive Rhythm Monitoring, Implantable Hemodynamic Monitoring, Functional Status Monitoring, and Noninvasive Mapping

Jonathan Weinstock; Munther K. Homoud; Mark S. Link; N.A. Mark Estes


Diagnosis and Management of Hypertrophic Cardiomyopathy | 2007

Hypertrophic Cardiomyopathy and Other Causes of Sudden Death in the Trained Athlete: An Electrophysiologist Perspective on the Management of Benign and not so Benign Arrhythmias

N.A. Mark Estes; Paul J. Wang; Munther K. Homoud; Mark S. Link


Diagnosis and Management of Hypertrophic Cardiomyopathy | 2007

Sudden Death Due to Chest Blows (Commotio Cordis)

Mark S. Link; N.A. Mark Estes; Barry J. Maron

Collaboration


Dive into the N.A. Mark Estes's collaboration.

Top Co-Authors

Avatar

Mark S. Link

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amit J. Shanker

American Association for Thoracic Surgery

View shared research outputs
Top Co-Authors

Avatar

Andrew E. Epstein

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barry J. Maron

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge